September 11, 2017 - HIV.gov BlogTOPICS: CDC, OHAIDP, Prevention, Treatment as Prevention, Viral Suppression The HHS Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) is coordinating a process across HHS agencies to ensure that they all consistently and accurately describe the effect of viral suppression on the risk of sexual transmission of HIV. As part of this process, last week CDC posted the following notice on its main HIV page... [READ MORE] September 11, 2017 - HIV.gov BlogTOPICS: OHAIDP, Prevention, Treatment as Prevention, Viral Suppression The HHS Office of HIV/AIDS and Infectious Disease Policy will host two listening sessions this month to discuss the work that HHS has been doing to review the game-changing studies on the impact of HIV antiretroviral treatment (ART) and viral suppression on the sexual transmission of HIV. These studies followed approximately 3,000 sexually active mixed HIV-status couples over many years—and observed no HIV transmissions while the HIV-positive partner was taking ART and virally suppressed... [READ MORE] | 
No hay comentarios:
Publicar un comentario